Heron Therapeutics | HRTX - Liquidités





Liquidités Changement Date
ALKERMES USD 351.55M 37.02M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amarin USD 131.06M 3.6M 2026-03
ANI Pharmaceuticals USD 311.18M 25.59M 2026-03
Anika Therapeutics USD 41.02M 16.46M 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
Eisai JPY 301.65B 16.27B 2025-09
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Esperion Therapeutics USD 156.16M 11.69M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
Heron Therapeutics USD 26.12M 2.53M 2026-03
Insmed USD 582.19M 71.74M 2026-03
Ligand Pharmaceuticals USD 115.08M 59.85M 2026-03
Merck USD 5.33B 9.24B 2026-03
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neurocrine Biosciences USD 266.5M 446.5M 2026-03
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 144.31M 14.24M 2026-03
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Ultragenyx Pharmaceutical USD 175M 246M 2026-03
Veracyte USD 263.14M 99.44M 2026-03
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03